3Tao CW,Yung HC,Hsin BL.Carvedilol,a pharmacolngical antioxidant,inhibits neointimal matrix metaUaproteinaso-2 and -9 in experimental atherosclerosis.Free Bad Biolo Med,2007,43:1508-1522.
4Zorina SG,Kazubiko A,Denis G,et al.N-Acetyl-cysteine decrease the matrix-degrading capacity of macrophage derive foam cell,Circulation,1998,97:2445-2453.
5Derosa G,D'Angelo A,Scalise F,et al.Comparison between metallopmteinases-2 and -9 in healthy subjects,diabetics,and subjects with acute coronary syndrome.Heart Vessels,2007,22:361-370.
6Sawayama Y,Tatsukawa M,Kikuchi K,et al.Effect on carotid atherosclerosis of probucol plus levofloxacin for chlamydia pneumoniae infection.J Infect Chem,2007,13:92-98.
7Iqbal M,Oknzaki Y,Okada S,et al.Probueol modulates iron nitrilotriacetate (Fe-NTA)-dependent renal carcinogenesis and hyperprollferative response:diminution of oxidative stress.Mol Cell Biochem.2007,304:61-69.
8Yoshikawa T,Mitani K,Kotosai K,et al.Antiatherogenic effects of cilostazol and probucol alone,and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.Horm Metab Res,2008,40:473-478.
9Tanous,D,Hime N,Stocker R,et al.Roland anti-atherosclerotic and anti-diabetic properties of probueol and related compounds.Redox Rep,2008,13:48-59.
10Wikxtrand J, Wiklund O. Frontiers in cardiovascular science: puantitative measurements of atherosclerotic in human[J]. Arterioscler Thromb, 1992,12(1): 114-119.
